Siemens Healthineers has announced the global availability of its new Atellica CH Enzymatic Hemoglobin A1c (A1c_E) assay to assist clinicians in diagnosing and monitoring diabetes, a growing and potentially deadly disease.
Atellica CH Enzymatic Hemoglobin A1c (A1c_E) assay.
The International Diabetes Federation projects that 642 million people worldwide will have diabetes by 2040, due to factors such as higher levels of urbanization, aging populations, and the growing adoption of more sedentary lifestyles leading to insufficient physical activity, greater rates of obesity, and a higher intake of unhealthy foods.1
When diagnosed, treated, and monitored regularly, diabetes is manageable and, in some cases, reversible. Left untreated, however, blood sugar can rise to dangerous levels and lead to kidney damage and other irreversible health consequences. And as diabetes awareness increases and screening for the chronic disease rises, testing options for the clinical laboratory are evolving both in sophistication and practicality.
Deepak Nath, PhD, Siemens Healthineers.
“Demands for screening and monitoring on the laboratory will continue to grow as the diabetic population continues to expand,” explains Deepak Nath, PhD, president of laboratory diagnostics at Siemens Healthineers. “Instruments with higher throughput capabilities offer laboratories the ability to run a greater volume of tests and produce patient results more quickly, thus improving patient satisfaction. Laboratories are seeking HbA1c assays that can be integrated onto chemistry testing platforms and that provide the accurate and precise results patients deserve. The new Atellica CH Enzymatic Hemoglobin A1c assay offers these capabilities.”
Siemens Healthineers offers a variety of HbA1c assays for diabetes testing on its clinical laboratory and point-of-care solutions, including the Atellica CH analyzer, Advia chemistry systems, Dimension systems, Dimension Vista systems, and the DCA Vantage analyzer.
For further information visit Siemens Healthineers.
Reference
- IDF Diabetes Atlas. 8th ed. Brussels: International Diabetes Federation, 2017. Available at: http://www.diabetesatlas.org. Accessed July 5, 2019.
Featured image
: courtesy of Siemens Healthineers.
